Year in review: Major business events in 2018

By Wang Junwei | chinadaily.com.cn | Updated: 2019-01-07 06:45
Share
Share - WeChat

Changsheng Biotech in safety scandal

Changsheng Biotech's logo. [Photo/VCG]

Vaccine maker Changsheng Biotech was involved in a safety scandal in July, when the State Drug Administration announced it found the company had engaged in falsifying production and inspection records in the manufacture of rabies vaccines.

The China Securities Regulatory Commission and China Food and Drug Administration imposed fines of 600,000 yuan ($86,500) and 9.1 billion yuan on Changsheng respectively. On Dec 11, the company received a mandatory delisting notification from the Shenzhen Stock Exchange.

On Dec 23, a new draft law that aims to intensify management of vaccines to ensure their safety and quality, approved by China's State Council, was submitted to the National People's Congress Standing Committee for approval.

|<< Previous 1 2 3 4 5 6 7 8 9 Next   >>|
Photo

Related Stories

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US